Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
•
Anticoagulation
Are there reliable data to support enoxaparin use in ESRD patients needing to bridge to warfarin for VTE history?
Related Questions
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Can lupus anticoagulant be positive despite a normal aPTT?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
Do you routinely check serum phosphorus levels after IV iron therapy?
In a patient with type I von Willebrand disease who is pregnant and at increased risk for preeclampsia, would you recommend treatment with aspirin?
